Reuters logo
BRIEF-AGTC files investigational NDA for treatment of achromatopsia
2016年10月19日 / 晚上8点27分 / 1 年前

BRIEF-AGTC files investigational NDA for treatment of achromatopsia

Oct 19 (Reuters) - Applied Genetic Technologies Corp

* AGTC files investigational new drug application for the treatment of Achromatopsia caused by mutations in the CNGA3 gene Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below